ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study

María Íñiguez, Patricia Pérez-Matute, Pablo Villoslada-Blanco, Emma Recio-Fernandez, Diana Ezquerro-Pérez, Jorge Alba, M. Lourdes Ferreira-Laso, José A. Oteo
doi: https://doi.org/10.1101/2021.03.24.21253576

Article usage

Article usage: March 2021 to August 2025

AbstractFullPdf
Mar 2021474269
Apr 2021182168
May 202185285
Jun 202186450
Jul 202171656
Aug 2021150768
Sep 202153046
Oct 202140131
Nov 202164235
Dec 202184019
Jan 202229325
Feb 202233129
Mar 202231018
Apr 202230221
May 202230016
Jun 202228069
Jul 202218260
Aug 20221918
Sep 202230213
Oct 202225010
Nov 20222808
Dec 202220113
Jan 202318014
Feb 202317210
Mar 202313114
Apr 202323110
May 20231216
Jun 20236411
Jul 20231216
Aug 20231587
Sep 202312412
Oct 20231114
Nov 20231218
Dec 20231113
Jan 20241236
Feb 202420211
Mar 202411312
Apr 2024636
May 202415911
Jun 20241438
Jul 202418010
Aug 202412416
Sep 20241218
Oct 20241677
Nov 202425521
Dec 202426017
Jan 202517112
Feb 202527149
Mar 2025362519
Apr 202530421
May 202516312
Jun 20253775
Jul 202514612
Aug 2025101
Back to top
Posted March 26, 2021.
Download PDF
Data/Code
Email
ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study
María Íñiguez, Patricia Pérez-Matute, Pablo Villoslada-Blanco, Emma Recio-Fernandez, Diana Ezquerro-Pérez, Jorge Alba, M. Lourdes Ferreira-Laso, José A. Oteo
medRxiv 2021.03.24.21253576; doi: https://doi.org/10.1101/2021.03.24.21253576
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area